Biochemical and Neurobehavioral Changes in the Rat Model of Parkinson’s Disease with Suprathreshold Exercise and Usnic Acid
Life Sciences-Neurosciences
DOI:
https://doi.org/10.22376/ijlpr.2023.13.1.L293-306Keywords:
Parkinson’s disease, above-the-threshold exercise, dopamine, Nurr1, HSP70, α-synuclein, antioxidant damage.Abstract
Finding a solution for Parkinson's disease has been a challenge to researchers despite advances in medicinal research. None of the options available so far has been able to reverse dopaminergic damage or increase endogenous dopamine production from existing dopaminergic cells in Parkinson's disease. Research in Parkinson’s disease has not so far resulted in finding better solutions for reversing dopaminergic damage or increasing dopamine production. Above-the-threshold (suprathreshold) exercises producing improvement have been documented with supporting clinical and imaging findings but without any biochemical evidence. Above-the-threshold (suprathreshold) exercises producing improvement in Parkinson's disease have been documented with supporting clinical and imaging findings. To the best of our knowledge, the biochemical basis of this improvement has not been studied in detail. Recently, biomolecules like usnic acid have been shown to improve dopamine levels through protective and regenerative effects. This study aimed at understanding the biochemical basis of the improvement following suprathreshold exercises and usnic acid. The objectives were to assess whether the suprathreshold exercise produces improvement in PD rat models and, if so, to understand the biochemical basis of improvement and compare the mechanism with that of usnic acid.The effect of suprathreshold exercise and usnic acid on Parkinson’s disease Hence, this study was conceived to understand whether the exercise produces results due to a similar mechanism that had never been reported before. Parkinson's disease was compared with rotenone alone, rotenone and high-fat diet models, and control. Induced with rotenone and a high-fat diet, the effect of suprathreshold exercise was compared to that of usnic acid, the rotenone alone model, and control. Locomotor behaviour was assessed with an actophotometer and rotarod. Western blotting assessed the blood biochemical parameters, antioxidant and dopamine levels in addition to α-synuclein, tyrosine hydroxylase, Nurr1, and HSP70 levels. Usnic acid decreased oxidative stress markers like MDA, peroxynitrite and nitric oxide, indicating lesser oxidative stress, increased dopamine and serotonin levels and decreased α-synuclein expression. But the suprathreshold exercise did not significantly affect oxidative stress markers nor increased dopamine levels. However, α-synuclein expression was decreased. Compared with usnic acid, lower Nurr1 levels in the suprathreshold group demonstrate lesser protective and regenerative effects on dopaminergic neurons. HSP70 levels indicate that improvement in suprathreshold exercise resulted from preventing misfolding of α-synuclein or through a noncanonical interaction, and comparable locomotor behaviour was observed in both groups. Biomolecules like brain-derived neurotropic factors produced by suprathreshold exercises acting centrally and in muscles might have also contributed to improvement in this group. When usnic acid increased dopamine levels in the brain through protective effects on dopaminergic neurons, antioxidant effects, and reduced expression of α-synuclein, suprathreshold exercise did not increase dopamine, decreased α-synuclein and had less antioxidant effects. This study biochemically proves that suprathreshold exercise alleviates Parkinson’s disease symptoms by preventing α-synuclein misfolding and not by mechanisms other than increasing dopamine, neuroprotection or regeneration of dopaminergic neurons, which require further studies in humans.
References
Zafar S, Yaddanapudi SS. Parkinson disease. StatPearls Publishing; 2019 Dec 4. InStatPearls. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470193/ [cited 12/29/2022].
Sontheimer H. Dis Nerv Syst. 2015:133-64.
Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012;8(6):329-39. doi: 10.1038/nrneurol.2012.80, PMID 22584158.
Ostrem JL, Galifianakis NB. Overview of common movement disorders. Continuum (Minneap Minn). 2010;16(1 Movement Disorders)(1 Movement Disorders):13-48. doi: 10.1212/01.CON.0000348899.02339.9d, PMID 22810179.
Münchau A, Bhatia KP. Pharmacological treatment of Parkinson’s disease. Postgrad Med J. 2000;76(900):602-10. doi: 10.1136/pmj.76.900.602, PMID 11009573.
Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548-60. doi: 10.1001/jama.2019.22360, PMID 32044947.
Karuppagounder SS, Madathil SK, Pandey M, Haobam R, Rajamma U, Mohanakumar KP. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats. Neuroscience. 2013;236:136-48. doi: 10.1016/j.neuroscience.2013.01.032, PMID 23357119.
Kumar DS, Sivanesan S, Rajagopalan D, Nair LDV. Development of Parkinson’s disease rat model in two weeks using corn oil and rotenone induction. Int J Pharm Sci Res. 2023;14(4):1000-13. doi: 10.13040/ijpsr.0975-8232.14(4).1000-13.
Pouratian N, Thakkar S, Kim W, Bronstein JM. Deep brain stimulation for the treatment of Parkinson’s disease: efficacy and safety. Degener Neurol Neuromuscul Dis. 2012 Sep 4;2012(2):107-17. doi: 10.2147/DNND.S25750, PMID 24298202, PMCID PMC3843969.
Stoker V, Krack P, Tonder L, Barnett G, Durand-Zaleski I, Schnitzler A, et al. Deep brain stimulation impact on social and occupational functioning in Parkinson’s disease with early motor complications. Mov Disord Clin Pract. 2020;7(6):672-80. doi: 10.1002/mdc3.13015, PMID 32775513.
Tarazi FI, Sahli ZT, Wolny M, Mousa SA. Emerging therapies for Parkinson’s disease: from bench to bedside. Pharmacol Ther. 2014;144(2):123-33. doi: 10.1016/j.pharmthera.2014.05.010, PMID 24854598.
Rosenthal LS, Dorsey ER. The benefits of exercise in Parkinson disease. JAMA Neurol. 2013;70(2):156-7. doi: 10.1001/jamaneurol.2013.772, PMID 23117841.
Oliveira de Carvalho A, Filho ASS, Murillo-Rodriguez E, Rocha NB, Carta MG, Machado S. Physical exercise for Parkinson’s disease: clinical and experimental evidence. Clin Pract Epidemiol Ment Health. 2018 Mar 30;14:89-98. doi: 10.2174/1745017901814010089, PMID 29785199, PMCID PMC5897963.
Ji L, Steffens DC, Wang L. Effects of physical exercise on the aging brain across imaging modalities: a meta-analysis of neuroimaging studies in randomized controlled trials. Int J Geriatr Psychiatry. 2021;36(8):1148-57. doi: 10.1002/gps.5510. PMID 33675074.
Morley D, Dummett S, Kelly L, Jenkinson C. Development of an Exercise-Specific Parkinson’s Disease Questionnaire: The PDQ-Exercise. Mov Disord. 2021;36(9):2156-61. doi: 10.1002/mds.28644. PMID 33991139.
Shaw JA, Huffman JL, Frank JS, Jog MS, Adkin AL. The effects of skill focused instructions on walking performance depend on movement constraints in Parkinson’s disease. Gait Posture. 2011;33(1):119-23. doi: 10.1016/j.gaitpost.2010.10.087, PMID 21094048.
Alberts JL, Linder SM, Penko AL, Lowe MJ, Phillips M. It is not about the bike, it is about the pedaling: forced exercise and Parkinson’s disease. Exerc Sport Sci Rev. 2011;39(4):177-86. doi: 10.1097/JES.0b013e31822cc71a, PMID 21799425.
Li J, Guo J, Sun W, Mei J, Wang Y, Zhang L, et al. Effects of exercise on Parkinson’s disease: A meta-analysis of brain imaging studies. Front Hum Neurosci. 2022;16:796712. doi: 10.3389/fnhum.2022.796712, PMID 35250515.
Lau YS, Patki G, Das-Panja K, Le WD, Ahmad SO. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration. Eur J Neurosci. 2011;33(7):1264-74. doi: 10.1111/j.1460-9568.2011.07626.x, PMID 21375602.
Marosi K, Bori Z, Hart N, Sárga L, Koltai E, Radák Z, et al. Long-term exercise treatment reduces oxidative stress in the hippocampus of aging rats. Neuroscience. 2012;226:21-8. doi: 10.1016/j.neuroscience.2012.09.001, PMID 22982624.
Cassilhas RC, Lee KS, Fernandes J, Oliveira MG, Tufik S, Meeusen R, et al. Spatial memory is improved by aerobic and resistance exercise through divergent molecular mechanisms. Neuroscience. 2012;202:309-17. doi: 10.1016/j.neuroscience.2011.11.029, PMID 22155655.
Hisahara S, Shimohama S. Toxin-induced and genetic animal models of Parkinson’s disease. Parkinsons Dis. 2010;2011:951709. doi: 10.4061/2011/951709, PMID 21234368.
Vijayaraghavan R, Selvaraj R, Krishna Mohan S, Gopi P. Haematological and biochemical changes in response to stress induced by the administration of amikacin injection by autoinjector in animals. Def Sci J. 2014;64(2):99-105. doi: 10.14429/dsj.64.5032.
Deacon RMJ. Measuring motor coordination in mice. J Vis Exp. 2013;75(75):e2609. doi: 10.3791/2609, PMID 23748408.
Sengupta P. The laboratory rat: relating its age with Human’s. Int J Prev Med. 2013;4(6):624-30. PMID 23930179, PMCID PMC3733029.
Sunmonu TO, Bayo Lewu F. Phytochemical analysis, in vitro antioxidant activity and inhibition of key diabetic enzymes by selected Nigerian medicinal plants with antidiabetic potential. IJPER. 2019;53(2):250-60. doi: 10.5530/ijper.53.2.33.
Mohun AF, Cook IJ. Simple methods for measuring serum levels of the glutamic-oxalacetic and glutamic-pyruvic transaminases in routine laboratories. J Clin Pathol. 1957;10(4):394-9. doi: 10.1136/jcp.10.4.394, PMID 13481132.
Mangalanathan M, Uthamaramasamy S, Venkateswaran R. Therapeutic effect of Zanthoxylum armatum Fruit on glycoproteins, biochemical changes and electrolytes in isoproterenol induced cardiotoxic rats. Int J Pharm Pharm Res. 2017;10(2):408-22.
Berthelot MP. Violet d’aniline [report]. Chimieappliquee. Vol. 1; 2019. p. 284.
Ekwempu A, Sariem, Comfort. Serum creatinine and urea levels in Wistar rats exposed to glacial acetic acid. The Trop J Health Sci. 2019;26:1.
Santhosh Kumar B, Diwakar M, Subramaniam S, Subramaniam S. Acute toxicity study and therapeutic activity of modified Arjunarishta on isoproterenol-induced myocardial infarction in rats. Int J Pharm Pharm Sci. 2022;14(5):12-21.
Shin H-S. Determination of malondialdehyde in human blood by headspace-solid phase micro-extraction gas chromatography–mass spectrometry after derivatization with 2,2,2-trifluoroethylhydrazine. J Chromatogr B. 2009;877(29):3707-11. doi: 10.1016/j.jchromb.2009.09.022.
Jabłońska E, Kiersnowska-Rogowska B, Ratajczak W, Rogowski F, Sawicka-Powierza J. Reactive oxygen and nitrogen species in the course of B-CLL. Adv Med Sci. 2007;52(1):154-8. PMID 18217409.
Beckman JS, Ischiropoulos H, Zhu L, van der Woerd M, Smith C, Chen J et al. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys. 1992;298(2):438-45. doi: 10.1016/0003-9861(92)90432-v, PMID 1416975.
Benzie IF, Strain JJ. Assessing age-related changes in antioxidant status: the FRASC assay for total antioxidant power and ascorbic acid concentration in biological fluids. Methods Mol Med. 2000;38:133-42. doi: 10.1385/1-59259-070-5:133, PMID 22351270.
Wang Z, Yang Y, Xiang X, Zhu Y, Men J, He M. [Estimation of the normal range of blood glucose in rats]. Wei Sheng Yan Jiu. 2010 Mar;39(2):133-7, 142. Chinese. PMID 20459020.
Marques A, Dutheil F, Durand E, Rieu I, Mulliez A, Fantini ML, et al. Glucose dysregulation in Parkinson’s disease: too much glucose or not enough insulin? Parkinsonism Relat Disord. 2018;55:122-7. doi: 10.1016/j.parkreldis.2018.05.026, PMID 29866628.
Goutianos G, Tzioura A, Kyparos A, Paschalis V, Margaritelis NV, Veskoukis AS et al. [internet] The rat adequately reflects human responses to exercise in blood biochemical profile: a comparative study. Physiol Rep. 2015;3(2):e12293. doi: 10.14814/phy2.12293, PMID 25677548.
Jain J, Hasan W, Jat D, Singh Yadav R, Biswas PProtective Role of Quercetin Against Rotenone- Induced Hepato and Nephrotoxicity in Swiss Albino Mice. International Journal of Human Anatomy. 2021;2(4):8-27. doi: 10.14302/issn.2577-2279.ijha-21-3869.
Xicoy H, Wieringa B, Martens GJM. The role of lipids in Parkinson’s disease. Cells. 2019;8(1):27. doi: 10.3390/cells8010027, PMID 30621069.
Yang TJ, Wu CL, Chiu CH. High-intensity intermittent exercise increases fat oxidation rate and reduces postprandial triglyceride concentrations. Nutrients. 2018;10(4):492. doi: 10.3390/nu10040492, PMID 29659529.
Lee CL, Kuo YH, Cheng CF. Acute high-intensity interval cycling improves postprandial lipid metabolism. Med Sci Sports Exerc. 2018;50(8):1687-96. doi: 10.1249/MSS.0000000000001613, PMID 29554012.
Carroll CB, Wyse RKH. Simvastatin as a potential disease-modifying therapy for patients with Parkinson’s disease: rationale for clinical trial, and current progress. J Parkinsons Dis. 2017;7(4):545-68. doi: 10.3233/JPD-171203, PMID 29036837.
Fernández-Moriano C, Divakar PK, Crespo A, Gómez-Serranillos MP. Protective effects of lichen metabolites evernic and usnic acids against redox impairment-mediated cytotoxicity in central nervous system-like cells. Food Chem Toxicol. 2017;105:262-77. doi: 10.1016/j.fct.2017.04.030, PMID 28450128.
Gavrilović L, Stojiljković V, Popović N, Pejić S, Todorović A, Pavlović I et al. Animal models for chronic stress-induced oxidative stress in the spleen: the role of exercise and catecholaminergic system. In: (Ed.). Experimental animal models of human diseases – an effective therapeutic strategy. IntechOpen; 2018. doi: 10.5772/intechopen.70008.
Grosch J, Winkler J, Kohl Z. Early degeneration of both dopaminergic and serotonergic axons - A common mechanism in Parkinson’s disease. Front Cell Neurosci. 2016;10:293. doi: 10.3389/fncel.2016.00293, PMID 28066188.
Kouli A, Torsney KM, Kuan WL. Parkinson’s disease: etiology, neuropathology, and pathogenesis; 2018 Dec 21. Chapter 1. Parkinson’s disease: pathogenesis and clinical aspects [internet]. Brisbane (AU): Codon Publications. In: Stoker TB, Greenland JC, editors. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536722/ [cited 12/29/2022].
Kaushik P, Gorin F, Vali S. Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis. J Comput Neurosci. 2007;22(2):147-60. doi: 10.1007/s10827-006-0004-8, PMID 17053993.
Olivares D, Huang X, Branden L, Greig NH, Rogers JT. Physiological and pathological role of alpha-synuclein in Parkinson’s disease through iron mediated oxidative stress; the role of a putative iron-responsive element. Int J Mol Sci. 2009 Mar;10(3):1226-60. doi: 10.3390/ijms10031226. PMID 19399246, PMCID PMC2672027.
Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH. Nurr1 in Parkinson’s disease and related disorders. J Comp Neurol. 2006;494(3):495-514. doi: 10.1002/cne.20828, PMID 16320253.
Argyrofthalmidou M, Spathis AD, Maniati M, Poula A, Katsianou MA, Sotiriou E, et al. Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice. Hum Mol Genet. 2021 Jul 28;30(16):1469-83. doi: 10.1093/hmg/ddab118, PMID 33902111, PMCID PMC8330896.
Kim CH, Han BS, Moon J, Kim DJ, Shin J, Rajan S et al.. Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease Proc Natl Acad Sci U S A. 2015;112(28):8756-61. doi: 10.1073/pnas.1509742112. PMID 26124091.
Moon H, Jeon SG, Kim JI, Kim HS, Lee S, Kim D et al. Pharmacological stimulation of Nurr1 promotes cell cycle progression in adult hippocampal neural stem cells. Int J Mol Sci. 2019;21(1):4. doi: 10.3390/ijms21010004, PMID 31861329.
Decressac M, Volakakis N, Björklund A, Perlmann T. NURR1 in Parkinson disease--from pathogenesis to therapeutic potential. Nat Rev Neurol. 2013;9(11):629-36. doi: 10.1038/nrneurol.2013.209, PMID 24126627.
Smith GA, Rocha EM, Rooney T, Barneoud P, McLean JR, Beagan J, et al. A Nurr1 agonist causes neuroprotection in a Parkinson’s disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C). PLOS ONE. 2015;10(3):e0121072. doi: 10.1371/journal.pone.0121072. PMID 25815475.
Tao J, Berthet A, Citron YR, Tsiolaki PL, Stanley R, Gestwicki JE, et al. HSP70 chaperone blocks α-synuclein oligomer formation via a novel engagement mechanism. J Biol Chem. 2021;296:(100613). doi: 10.1016/j.jbc.2021.100613, PMID 33798554.
Krüger K, Reichel T, Zeilinger C. Role of heat shock proteins 70/90 in exercise physiology and exercise immunology and their diagnostic potential in sports. J Appl Physiol (1985). 2019;126(4):916-27. doi: 10.1152/japplphysiol.01052.2018, PMID 30730806.
Leem YH, Park JS, Park JE, Kim DY, Kim HS. Neurogenic effects of rotarod walking exercise in subventricular zone, subgranular zone, and substantia nigra in MPTP-induced Parkinson’s disease mice. Sci Rep. 2022;12(1):10544. doi: 10.1038/s41598-022-14823-5, PMID 35732806.
Chen YH, Kuo TT, Kao JH, Huang EY, Hsieh TH, Chou YC et al. Exercise ameliorates motor deficits and improves dopaminergic functions in the rat hemi-Parkinson’s model. Sci Rep. 2018 Mar 5;8(1):3973. doi: 10.1038/s41598-018-22462-y, PMID 29507426, PMCID PMC5838260.
Zhou W, Barkow JC, Freed CR. Running wheel exercise reduces α-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson’s disease. PLOS ONE. 2017 Dec 22;12(12):e0190160. doi: 10.1371/journal.pone.0190160, PMID 29272304, PMCID PMC5741244.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Devika Sanil Kumar, Senthilkumar Sivanesan, Lal Devayani Vasudevan Nair, Rajagopalan Vijayaraghavan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

